The KX Modifier: When DME Suppliers Use It and What It Attests

2026-10-05 · Caduvo Team

Understand what the KX modifier attests on Medicare DMEPOS claims, which policies mandate it, audit risks, and how it coordinates with GA, GY, and GZ.

Appending the KX modifier to a Medicare claim line takes two seconds in billing software. That keystroke bypasses automated claim edits and triggers immediate payment. It also functions as a formal, binding attestation certifying that the patient meets every coverage requirement in the applicable medical policy and that documentation supporting medical necessity is on file.

Treating the KX modifier as an administrative shortcut creates severe post-payment audit exposure. Durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) suppliers face overpayment clawbacks when audit contractors discover patient files lacking a qualifying clinical finding, an order, or a timely face-to-face evaluation. Compliance requires understanding what the modifier attests, which policies mandate its use, and how it coordinates with Medicare liability modifiers.

What the KX Modifier Attests to Medicare Contractors

Medicare defines modifier KX as a direct certification: "Requirements specified in the medical policy have been met." According to Noridian DME MAC guidance on modifier KX, appending KX indicates that the supplier has ensured coverage criteria for the DMEPOS billed are met and that documentation exists to support the medical necessity of the item, available upon request.

The KX modifier is one of several Level II hcpcs modifiers designed to communicate clinical eligibility directly to payers. Appending KX without verifying coverage criteria and supporting documentation constitutes incorrect use, exposing the supplier to recoupment upon medical review.

Suppliers must also follow procedural claim handling rules. As noted in Noridian guidance, unprocessable claims returned with remark code MA130 carry no administrative appeal rights; they must be corrected and resubmitted. Policy-specific instructions also dictate when to withhold the modifier. Under the Glucose Monitors and Testing Supplies policy, suppliers must append modifier KX to claims when the beneficiary is treated with insulin injections. If the beneficiary is not treated with insulin injections, the KX modifier must not be appended, even though testing supplies may otherwise be covered under standard policy guidelines.

DMEPOS Policies That Require the KX Modifier

DME MACs require the KX modifier across dozens of active local coverage determinations, ranging from transcutaneous electrical nerve stimulators (TENS), negative pressure wound therapy pumps, and hospital beds to high frequency chest wall oscillation devices and speech generating devices. In several high-volume product categories, MACs mandate that every claim line carry KX or an alternative liability modifier (GA, GY, or GZ). If a claim omits these mandatory hcpcs code modifiers, the contractor's claims processing system rejects the line as missing information.

1. Oxygen and Oxygen Equipment (LCD L33797)

Under the Oxygen and Oxygen Equipment Local Coverage Determination (LCD L33797), a joint DME MAC publication posted on December 29, 2022 reminds suppliers that claim lines billed without a KX, GA, GY, or GZ modifier will be rejected as missing information. Appending KX certifies that all statutory and reasonable and necessary requirements in LCD L33797 have been met. Suppliers are not required to secure all documentation prior to claim submission; however, appending KX to each billed oxygen code attests that policy requirements have been satisfied.

2. Enteral and Parenteral Nutrition

For dates of service on or after July 2, 2023, DME MACs mandate a KX, GA, GY, or GZ modifier on all enteral and parenteral nutrition claims, covering nutrition solutions, pumps, and supplies. As detailed in Noridian's enteral and parenteral modifier policy, submitting a claim line without one of these modifiers results in an immediate rejection for missing information. Appending KX serves as an attestation that statutory and reasonable and necessary requirements are met.

3. External Infusion Pumps (LCD L33794 and Policy Article A52507)

Under Noridian external infusion pump instructions, LCD L33794 and Policy Article A52507 require that claims for external infusion pumps, associated drugs, and supplies include a KX, GA, or GZ modifier, or face rejection. This billing rule applies across all categories of external infusion pumps, including insulin and non-insulin pumps, along with related supplies and drugs. Appending KX certifies that all coverage requirements and medical necessity standards in the LCD have been met and supporting documentation is retained.

4. Therapeutic Shoes for Persons with Diabetes (TSPD)

Under Noridian's TSPD compliance guidelines, Medicare coverage is limited to one pair of therapeutic shoes and up to three pairs of inserts or modifications per calendar year. To bill with modifier KX, suppliers must confirm documented clinical criteria:

The patient has a documented diagnosis of diabetes mellitus.
The patient has at least one qualifying condition: neuropathy with callus formation, previous ulceration, foot deformity, poor circulation, or partial foot amputation.
The certifying physician managing the patient's diabetes provides written certification of medical necessity.
The certifying physician conducts a face-to-face visit with the patient within six months prior to shoe delivery.

Suppliers must maintain complete records available upon request, including physician certifications, fitting notes, and delivery documentation.

5. Positive Airway Pressure (PAP) Devices

For positive airway pressure devices billed under code E0601, Noridian includes the Positive Airway Pressure Devices for the Treatment of Obstructive Sleep Apnea LCD on its list of active policies requiring the KX modifier. Appending KX to code E0601 attests that the beneficiary satisfies the clinical coverage criteria outlined in the PAP LCD and that medical documentation supporting coverage is on file.

6. Part B Outpatient Therapy Thresholds

The KX modifier is also used outside DMEPOS for Part B therapy services under CMS RAC Topic 0228. Under this complex review issue spanning all A/B MAC jurisdictions, Recovery Audit Contractors review physical therapy codes (97110, 97112, 97140, 97161, 97162, and 97163), occupational therapy codes (97165, 97166, 97530, and G0283), and speech-language pathology codes (92507). Clinicians append the KX modifier to attest that services at and above the therapy threshold are medically reasonable and necessary, with justification documented in the medical record.

Coordinating the KX, GA, GY, and GZ Modifiers

When a beneficiary does not satisfy policy criteria, suppliers must never append the KX modifier. Instead, suppliers must append an appropriate liability modifier to signal why the item is not covered and who bears financial responsibility. Medicare billing rules specify that the KX modifier must not be appended on the same claim line as GA, GY, or GZ.

Selecting the correct modifier depends on whether the denial stems from medical necessity or a statutory benefit exclusion, and whether an Advance Beneficiary Notice of Noncoverage (ABN) was executed prior to delivery:

When an item does not meet reasonable and necessary criteria and an initial claim denial is expected, the supplier must issue an ABN before furnishing the item. If the beneficiary signs a valid ABN, the supplier submits the claim with modifier GA appended to each corresponding HCPCS code, resulting in a medical necessity denial holding the beneficiary liable. If the ABN is invalid, GA must not be used.

If reasonable and necessary criteria are not met and the supplier lacks a valid ABN, the supplier must append modifier GZ. A claim submitted with modifier GZ receives a medical necessity denial holding the supplier liable, prohibiting billing to the beneficiary.

The GY modifier indicates that an item or service is statutorily excluded or does not meet the definition of any Medicare benefit. For example, while oxygen and oxygen equipment is covered under the Durable Medical Equipment benefit defined in Social Security Act §1861(s)(6), failing to satisfy statutory requirements justifies using modifier GY. Medicare denies claims billed with GY as statutorily noncovered and holds the beneficiary liable without requiring an ABN.

Audit Exposure: The Cost of Unsupported KX Submissions

Because claims billed with modifier KX clear automated edits, Medicare contractors pay them during initial adjudication without manual record review. This creates significant downstream liability during post-payment audits.

In OIG Report A-04-10-04004, the Department of Health and Human Services Office of Inspector General evaluated DMEPOS claims across Jurisdictions A, B, C, and D. The OIG estimated that DME MAC contractors paid approximately $316.4 million to suppliers that did not have the required documentation on file to support DMEPOS items billed with the KX modifier for 2007 dates of service. Contractor electronic edits could not verify supporting documentation during initial processing.

The OIG recommended that CMS recover unallowable payments identified in audits, develop corrective action plans for KX oversight, take enforcement action against suppliers failing proof of delivery standards, and issue special alerts detailing documentation required to support KX billing.

MedTech reimbursement teams use platforms like Caduvo to monitor LCD coverage criteria across jurisdictions, ensuring clinical parameters and documentation elements are defined before products enter commercial distribution.

Protocols for Defensible KX Billing

To safeguard cash flow under the medicare dme fee schedule, suppliers must enforce strict controls before appending modifier KX:

Stop Automatic Modifier Population: Never configure billing software to append KX automatically upon selecting an HCPCS code. Modifier appending must be tied to verified policy criteria.
Review Policy-Specific Triggers: Audit clinical indications against the exact LCD text. For therapeutic shoe claims, verify written certification from the managing physician and confirm a documented face-to-face visit occurred within six months prior to delivery.
Apply Exception Rules Accurately: Check whether the policy restricts KX to specific patient subgroups. Under the Glucose Monitors and Testing Supplies policy, confirm the patient is receiving insulin injections before adding KX; withhold the modifier if the patient is non-insulin treated.
Execute ABN Protocols When Coverage Is Uncertain: When an item does not meet reasonable and necessary criteria, obtain a signed ABN before dispensing and bill with modifier GA. If no valid ABN exists, append GZ and accept supplier liability instead of submitting an unsupported KX attestation.
Maintain Records for Immediate Production: Retain detailed orders, physician certifications, fitting notes, and delivery slips. When MACs or RAC auditors issue Additional Documentation Requests (ADRs), produce the complete record promptly to defend your claim.

Sources

General information, not regulatory, legal or reimbursement advice. Company and product names belong to their owners; a mention does not imply affiliation or endorsement. Report an error. Data and corrections policy.